Evidence map›Paper›PMID 34803964›Full record

ArticleFrontiers in microbiology2021

Two New Dihydrosphingosine Analogs Against

Katia Peñuelas-Urquides, Mario Bermúdez de León, Beatriz Silva-Ramírez, Fabiola Castorena-Torres, Gloria María Molina-Salinas, Jorge Castro-Garza, Pola Becerril-Montes, Esther Del Olmo, Arturo San Feliciano, Laura Adiene González-Escalante and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Katia Peñuelas-UrquidesDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Mario Bermúdez de LeónDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Beatriz Silva-RamírezDepartamento de Inmunogenética, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Fabiola Castorena-TorresTecnologico de Monterrey, Escuela de Medicina, Monterrey, Mexico.
Gloria María Molina-SalinasUnidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad, Hospital de Especialidades Centro Médico Nacional Ignacio García Téllez, Instituto Mexicano del Seguro Social, Mérida, Mexico.
Jorge Castro-GarzaLaboratorio de Patogénesis Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Pola Becerril-MontesDepartamento de Biología Celular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Esther Del OlmoDepartamento de Ciencias Farmacéuticas, Área de Química Farmacéutica, Facultad de Farmacia, Centro de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain.
Arturo San FelicianoDepartamento de Ciencias Farmacéuticas, Área de Química Farmacéutica, Facultad de Farmacia, Centro de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain.
Laura Adiene González-EscalanteDepartamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
Licet Villarreal-TreviñoFacultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), San Nicolás de los Garza, Mexico.
Salvador Said-FernándezDepartamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey, Mexico.
Mexican Social Security Institute · MXUniversidad Autónoma de Nuevo León · MXInstituto de Investigación Biomédica de Salamanca · ESTecnológico de Monterrey · MXUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of multidrug-resistant (MDR)

Indexed as

antitubercular drugsdihydrosphingosine analogsgene expressionmultidrug-resistanceMycobacterium tuberculosis

Identifiers

PMID34803964
PMCPMC8595602
OpenAlexW3210375577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.